OOIR: Observatory of International Research

Papers

(The TQCC of Arthritis & Rheumatology is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)

Article	Citations
	795
Reply	294
Sex Differences in B Cells From the Joints of Children With Oligoarticular Juvenile Idiopathic Arthritis	210
Efficacy, Safety, Pharmacokinetics, and Immunogenicity of ABBV‐154 in Adults With Glucocorticoid‐Dependent Polymyalgia Rheumatica: A Phase 2, Randomized, Double‐Blind, Placebo‐Controlled Tr	158
	151
COVID‐19 vaccine uptake and vaccine hesitancy in rheumatic disease patients receiving immunomodulatory therapies in community practice settings	149
Long‐Term Safety and Efficacy of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis	148
CCL19‐Positive Lymph Node Stromal Cells Govern the Onset of Inflammatory Arthritis via Tropomyosin Receptor Kinase	133
Derivation of a Multivariable Psoriatic Arthritis Risk Estimation Tool (PRESTO): A Step Towards Prevention	127
Contribution of Interleukin‐4–Induced Epithelial Cell Senescence to Glandular Fibrosis in IgG4‐Related Sialadenitis	125
Identification of Shared and Asian‐Specific Loci for Systemic Lupus Erythematosus and Evidence for Roles of Type III Interferon Signaling and Lysosomal Function in the Disease: A	125
Role of Glutaminase 2 in Promoting CD4+ T Cell Production of Interleukin‐2 by Supporting Antioxidant Defense in Systemic Lupus Erythematosus	120
Efficacy and Safety of Subcutaneous Abatacept Plus Standard Treatment for Active Idiopathic Inflammatory Myopathy: Phase 3 Randomized Controlled Trial	106
NLRP3 Attenuates Intraocular Inflammation by Inhibiting AIM2‐Mediated Pyroptosis Through the Phosphorylated Salt‐Inducible Kinase 1/Sterol Regulatory Element Binding T	104
Improvement in Disease Activity in Refractory Juvenile Dermatomyositis Following Abatacept Therapy	101
Clinical Connections	100
Correction to “Novel Genetic Loci in Early‐Onset Gout Derived From Whole‐Genome Sequencing of an Adolescent Gout Cohort”	97
In This Issue	92
Minimal tofacitinib dose for maintenance in axial spondyloarthritis: real‐world data from a resource‐limited setting	92
Clinical Connections	91
In This Issue	90
Endogenous Retroelement Activation is Implicated in Interferon‐α Production and Anti–Cyclic Citrullinated Peptide Autoantibody Generation in Early Rheumatoid Arthritis	89
Efficacy and Safety of ABBV‐3373, a Novel Anti–Tumor Necrosis Factor Glucocorticoid Receptor Modulator Antibody–Drug Conjugate, in Adults with Moderate‐to‐Severe Rheumatoid Arthr	87
Systemic lupus erythematosus and atherosclerosis progression risk: comment on the article by Papazoglou et al.	81
Classification Criteria for Axial Disease in Youth With Juvenile Spondyloarthritis	81

Alteration of Gut Microbiota in Individuals at High‐Risk for Rheumatoid Arthritis Associated With Disturbed Metabolome and the Initiation of Arthritis Through the Triggering of Mucosal Immu	80
Incidence, Prevalence, and Mortality of Lupus Nephritis: A Population‐Based Study Over Four Decades Using the Lupus Midwest Network	72
2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases	68
Gut Microbiome and Osteoarthritis: Insights From the Naturally Occurring Canine Model of Osteoarthritis	68
A Randomized, Double‐Blind, Placebo‐Controlled Trial of Abatacept for the Treatment of Relapsing, Nonsevere Granulomatosis With Polyangiitis	64
Assessing the Immune Cell Subset and Genetic Mutations in Patients With Palindromic Rheumatism Seronegative for Rheumatoid Factor and Anti–Cyclic Citrullinated Peptide	63
Seronegative palindromic rheumatism: what are we talking about? Comment on the article by Yang et al	61
No differences in myocardial perfusion between treatment‐naive, early rheumatoid arthritis patients and healthy controls	61
The Evolving Role of the Rheumatology Practitioner in the Care of Immunocompromised Patients in the COVID‐19 Era	60
At the Heart of Treating Kawasaki Disease: The Search for New Approaches to Prevent Coronary Artery Aneurysms	60
Association of change in metabolic syndrome status with altered risk of incident gout: comment on the article by Eun et al	57
Possible confounding factors explaining data on heart failure risk in patients with polymyositis/dermatomyositis: comment on the article by Lin et al	56
Targeting the Myddosome in Systemic Autoimmunity: Ready for Prime Time?	56
Pregnancy Outcomes in Women With Psoriatic Arthritis in Relation to Presence and Timing of Antirheumatic Treatment	56
The Devil Is in the Detail: Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty	56
Clinical Images: Rice bodies in pseudogout	54
Using Mice to Model Human Osteoarthritis: Age, Biologic Sex, and Pain Matter	53
Reply	53
Higher alcohol consumption was associated with greater incidence of total hip replacement due to hip osteoarthritis in a dose‐dependent manner in women: comment on the article by Marchand et al	53
Disturbed Spatial WNT Activation—A Potential Driver of the Reticularized Skin Phenotype in Systemic Sclerosis	52
Knee Alignment Correction by High Tibial Osteotomy Reduces Symptoms and Synovial Inflammation in Knee Osteoarthritis Accompanied by Macrophage Phenotypic Change From M1 to M2	51
Phase III/IV, Randomized, Fifty‐Two–Week Study of the Efficacy and Safety of Belimumab in Patients of Black African Ancestry With Systemic Lupus Erythematosus	51
A methodologic problem and a conceptual issue related to the new 2022 antineutrophil cytoplasmic antibody–related vasculitis criteria sets: comment on criteria sets approved by the American College of	51
Interleukin‐13 Receptor α1–Mediated Signaling Regulates Age‐Associated/Autoimmune B Cell Expansion and Lupus Pathogenesis	50
The Interleukin‐1 Receptor–Associated Kinase 4 Inhibitor PF‐06650833 Blocks Inflammation in Preclinical Models of Rheumatic Disease and in Humans Enrolled in a Randomized Clinical Trial	48
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria	48
Winner of the 2021 American College of Rheumatology Annual Image Competition	48
	48
	47
Hypoxia Promotes the Expression of ADAM9 by Tubular Epithelial Cells, Which Enhances Transforming Growth Factor β1 Activation and Promotes Tissue Fibrosis in Patients With Lupus Nephritis	46
Effect of Secukinumab Versus Adalimumab Biosimilar on Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: Results From a Head‐to‐Head Randomized Phase IIIb<	45
	45
	45
Reply	44
Journal Club	44
Journal Club	44
ACR Announcements	44
Journal Club	44
Vertebral Bone Mineral Density, Vertebral Strength, and Syndesmophyte Growth in Ankylosing Spondylitis: The Importance of Bridging	44
In This Issue	44
Efficacy of Golimumab in Early Axial Spondyloarthritis in Relation to Gut Inflammation (GO‐GUT), an Early Remission Induction Study	43
Reply	42
Clinical Connections	42
Role of autoantibodies in lupus nephritis: comment on the article by Fava et al	42
Issue Information	42
Reply	41
Reply	41
Reply	40
Reply	39
Reply	39

Tocilizumab in Giant Cell Arteritis: Better Understanding the Benefits	38
Immediate Open Access: The Good, the Bad, and the Impact on Academic Society Publishing	38
Not Only Excruciating Pain: Might a Gout Flare Episode Lead to Pulmonary Embolism?	38
Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic Polyangiitis	37
Neutrophil Activation Markers and Rheumatoid Arthritis Treatment Response to the JAK1/2 Inhibitor Baricitinib	37
Using Two Predictive Models to Capture Two Types of Poor Outcomes in Knee Arthroplasty: A Multisite Longitudinal Cohort Study	37
Effects of Anti–Tumor Necrosis Factor Therapy on Osteoblastic Activity at Sites of Inflammatory and Structural Lesions in Radiographic Axial Spondyloarthritis: A Prospective Proof‐of‐Concept	37
Oxidative Stress by the Mitochondrial Monoamine Oxidase B Mediates Calcium Pyrophosphate Crystal–Induced Arthritis	37
Revisiting the Synovium as a Structural Correlate of Pain in Osteoarthritis	37
Effect of Recent Antirheumatic Drug on Features of Rheumatoid Arthritis–Associated Lymphoproliferative Disorders	37
Strong Association of Combined Genetic Deficiencies in the Classical Complement Pathway With Risk of Systemic Lupus Erythematosus and Primary Sjögren's Syndrome	36
Clinical Image: Nasal rim sign: A clinical manifestation of dermatomyositis	36
Development and External Validation of a Model Predicting New‐Onset Chronic Uveitis at Different Disease Durations in Juvenile Idiopathic Arthritis	36
Longitudinal Analysis of Somatic Mosaicism and Clonal Hematopoiesis in Cryopyrin‐Associated Periodic Syndrome	36
The 2024 Vasculitis Foundation Quality Care Summit: Seeking Strategies to Improve Care for All Patients	36
Lysosome‐Associated Membrane Protein 3 Induces Lysosome‐Dependent Cell Death by Impairing Autophagic Caspase 8 Degradation in the Salivary Glands of Individuals With Sjögren's Di	36
Effects of Secukinumab on Enthesiophyte and Erosion Progression in Psoriatic Arthritis: A One‐Year Double‐Blind, Randomized, Placebo‐Controlled Trial Using High‐Resolution Peripheral Quantitative Comp	36
No Added Value of Duloxetine in Patients With Chronic Pain due to Hip or Knee Osteoarthritis: A Cluster‐Randomized Trial	35
Critical Role of Notch‐1 in Mechanistic Target of Rapamycin Hyperactivity and Vascular Inflammation in Patients With Takayasu Arteritis	34
Variability of Primary Sjögren's Syndrome Is Driven by Interferon‐α and Interferon‐α Blood Levels Are Associated With the Class II HLA–DQ Locus	34
Proteomic Profiling of the Large‐Vessel Vasculitis Spectrum Identifying Shared Signatures of Innate Immune Activation and Stromal Remodeling	34
Superiority of Low‐Dose Benzbromarone to Low‐Dose Febuxostat in a Prospective, Randomized Comparative Effectiveness Trial in Gout Patients With Renal Uric Acid Underexcretion	34
	33
In This Issue	33
Issue Information ‐ General Info	33
Journal Club	33
Reply	33
Clinical Connections	33
Programmed Death Ligand 1–Expressing Macrophages and Their Protective Role in the Joint During Arthritis	33
Reply	32
Reply	32
The genetic contribution of inflammation to the increased risk of cardiovascular disease in rheumatoid arthritis: comment on the article by Yuan et al	32
Serologic Biomarkers of Progression Toward Diagnosis of Rheumatoid Arthritis in Active Component Military Personnel	32
Clinical Images: Increased bone metabolism in secondary hyperparathyroidism	32
Heightened Proinflammatory Glycosylation of Borrelia burgdorferi IgG Antibodies in Synovial Fluid in Patients With Antibiotic‐Refractory Lyme Arthritis	32
Clinical Images: Burton line and scar hyperpigmentation in a patient with severe lead poisoning and saturnine gout	32
Changes in Descending Pain Modulation During Anti–Tumor Necrosis Factor Therapy: A Prospective Study in Rheumatoid Arthritis and Spondyloarthritis	32
Role of Human Mesenchymal Stem Cells and Derived Extracellular Vesicles in Reducing Sensory Neuron Hyperexcitability and Pain Behaviors in Murine Osteoarthritis	31
Corrigendum	31
Reply	31
Choosing to End African American Health Disparities in Patients With Systemic Lupus Erythematosus	31
ZBTB20 Regulating Postnatal Articular Cartilage Development and Homeostasis: Implications for Early‐Onset Osteoarthritis	31
Trends in New Use of Disease‐Modifying Antirheumatic Drugs for Juvenile Idiopathic Arthritis Among Commercially Insured Children in the United States from 2001 to 2022	31
Mucosal‐Associated Invariant T Cells in Rheumatic Diseases	30
Global burden of osteoarthritis attributable to high body mass index, 1990 to 2021: insights from the Global Burden of Disease study 2021: comment on the article by Lu et al	30
A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritis	30
Reply	30
Clinical Images: Transient perivascular inflammation of the carotid artery syndrome	30
An investigation of the relationship between weight management and gout: insights from the THIN database study and recommendations for improvement. Comment on the article by Wei et al	30
Screening of Environmental Chemicals to Characterize Exposures in Participants With Systemic Lupus Erythematosus	29
Doctor versus artificial intelligence: patient and physician evaluation of large language model responses to rheumatology patient questions: comment on the article by Ye et al	29
The Efficacy of Short‐Term Bridging Strategies With High‐ and Low‐Dose Prednisolone on Radiographic and Clinical Outcomes in Active Early Rheumatoid Arthritis: A Double‐Blin	29
Hydroxychloroquine dose after hospitalization for systemic lupus erythematosus: comment on the article by Nestor et al	28
EAT‐Lancet Diet Modifies the Risk of Rheumatoid Arthritis Through Metabolomic Signature	28
Reply	28
In This Issue	28
A Risk Score to Detect Subclinical Rheumatoid Arthritis–Associated Interstitial Lung Disease	28
Global Rheumatology Research: Frontiers, Challenges, and Opportunities	28
EULAR/American College of Rheumatology Classification Criteria for Pediatric Chronic Nonbacterial Osteomyelitis	28
Biosimilar Competition for Humira Is Here: Signs of Hope Despite Early Hiccups	28
Effect of time to start of biologic therapy on treatment response in childhood arthritis: Results from the UCAN CAN‐DU study	28
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Granulomatosis With Polyangiitis	27
A 24‐Week, Phase IIa, Randomized, Double‐Blind, Placebo‐Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis	27
Strength Training is Associated With Less Knee Osteoarthritis: Data From the Osteoarthritis Initiative: Comment on the Article by Lo et al	27
Artificial Intelligence and Deep Learning for Rheumatologists	27
Clinical images: VEXAS syndrome presenting as treatment‐refractory polyarteritis nodosa	27
Retraction	27
Serum Urate–Lowering Efficacy and Safety of Tigulixostat in Gout Patients With Hyperuricemia: A Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Finding Trial	27
	27
ADAM9 Promotes Glycolysis in Th17 Cells and Autoimmunity Through Activation of IGF‐1 Signaling	27
Genome‐Wide Association Study Identifies the First Germline Genetic Variant Associated With Erdheim‐Chester Disease	26
Journal Club	26
Concordance between ultrasound and physical examination in enthesitis assessment: a call for further investigation: comment on the article by Di Matteo et al	26
Circulating interferon alpha protein measured with digital enzyme‐linked immunosorbent assay as a biomarker for modified Rodnan skin score progression in limited systemic sclerosis: comment on the art	26
Efficacy and Safety of Sodium–Glucose Cotransporter 2 Inhibitors for the Primary Prevention of Cardiovascular, Renal Events, and Safety Outcomes in Patients With Systemic Lupus Erythematosus and Comor	26
The oral microbiota in persons at risk for rheumatoid arthritis: follow‐up data for the article by Kroese et al	26
Local Ancestry at the Major Histocompatibility Complex Region is Not a Major Contributor to Disease Heterogeneity in a Multiethnic Lupus Cohort	26
Clinical Connections	26
Journal Club	26
Plasma Proteomic Profiles Predict Individual Future Osteoarthritis Risk	26

Weight Reduction and Target Serum Urate Level: A Longitudinal Study of Annual Medical Examination	26
Issue Information	26
Associations and Diagnostic Accuracy of Ultrasound Features in Knee Osteoarthritis: Cross‐sectional Results from a Large Community‐based Cohort: comment on the article by Yates KA et al.	26
Should lipoprotein(a) be routinely measured after COVID‐19? Comment on the article by Stahl et al	25
Short‐term risk of cardiovascular events in people newly diagnosed with gout: comment on the article by Cipolletta et al	25
Addressing readability of online patient materials: comment on the American College of Rheumatology online information pages for patients and caregivers	25
Nuclear Receptor Subfamily 4A Signaling as a Key Disease Pathway of CD1c+ Dendritic Cell Dysregulation in Systemic Sclerosis	25
Clinical images: Huriez syndrome, a rare scleroderma mimic	25
Erratum	25
Reply	24
The Transition From Residency to Fellowship: Enhancing Training by Increasing Transparency	24
Do We Need More Exercise and Osteoarthritis Randomized Clinical Trials?	24
Transforming Rheumatology Practice With Technology: Products, Processes, People, and Purpose	24
Reply	24
Reply	24
Hypoxia‐Induced Synovial Fibroblast Activation in Inflammatory Arthritis and the Role of Notch‐1 and Notch‐3 Signaling: Comment on the Article by Chen et al	24
Increased risk of statin‐associated autoimmune myopathy among American Indians	23
Hand Swelling and Other Non–Raynaud Phenomenon Symptoms as the Initial Presentation of Systemic Sclerosis: Prevalence and Clinical Associations in Two US Cohorts	23
Two Distinct Immune Cell Signatures Predict the Clinical Outcomes in Patients With Amyopathic Dermatomyositis With Interstitial Lung Disease	23
Cartilage Acidic Protein 1 in Plasma Associates With Prevalent Osteoarthritis and Predicts Future Risk as Well as Progression to Joint Replacements: Results From the UK Biobank Resource	23
Reply	23
Mapping and Analysis of Protein and Gene Profile Identification of the Important Role of Transforming Growth Factor Beta in Synovial Invasion in Patients With Pigmented Villonodular Synovitis	23
Reply	23
Differences in IgG Sialylation Distinguish Asymptomatic from Symptomatic Anti‐Nuclear Antibody Positive Individuals	23
Skeletal Muscle Composition, Power, and Mitochondrial Energetics in Older Men and Women With Knee Osteoarthritis	23
Association of Autoantibody Concentrations and Trajectories With Lupus Nephritis Histologic Features and Treatment Response	23
Promotion of Joint Degeneration and Chondrocyte Metabolic Dysfunction by Excessive Growth Hormone in Mice	23
Epigenetic Regulation of Profibrotic Macrophages in Systemic Sclerosis–Associated Interstitial Lung Disease	23
Critical Role for Transglutaminase 2 in Scleroderma Skin Fibrosis and in the Development of Dermal Sclerosis in a Mouse Model of Scleroderma	23
Association of ¹⁸F‐Fluorodeoxyglucose–Positron Emission Tomography Activity With Angiographic Progression of Disease in Large Vessel Vasculitis	23
Complement	23
Systemic autoimmune rheumatic disease risk is associated with long‐term exposure to fine particulate matter: comment on the article by Geslin et al	22
Effects of B Cell Depletion by CD19‐Targeted Chimeric Antigen Receptor T Cells in a Murine Model of Systemic Sclerosis	22
Correspondence and comments on American College of Rheumatology and EULAR antiphospholipid syndrome classification criteria: comment on the article by Barbhaiya et al	22
Issue Information	22
Host Genetics But Not Commensal Microbiota Determines the Initial Development of Systemic Autoimmune Disease in BXD2 Mice	22
Predictors of Rheumatic Immune‐Related Adverse Events and De Novo Inflammatory Arthritis After Immune Checkpoint Inhibitor Treatment for Cancer	22
Journal Club	22
In This Issue	21
Impaired Efferocytosis by Synovial Macrophages in Patients With Knee Osteoarthritis	21
RNA Externalized by Neutrophil Extracellular Traps Promotes Inflammatory Pathways in Endothelial Cells	21
Identification of Novel Loci Shared by Juvenile Idiopathic Arthritis Subtypes Through Integrative Genetic Analysis	21
The Characteristics of Patients With COVID‐19–Associated Pediatric Vasculitis: An International, Multicenter Study	21
	21
	21
Single‐Cell Profiling of Bone Marrow B Cells and Early B Cell Developmental Disorders Associated With Systemic Lupus Erythematosus	21
Expert Perspective: Hematologic Malignancies and Vasculitis	21
Clinical Connections	21
Platelet Phagocytosis via P‐selectin Glycoprotein Ligand 1 and Accumulation of Microparticles in Systemic Sclerosis	21
Association of a Combination of Healthy Lifestyle Behaviors With Reduced Risk of Incident Systemic Lupus Erythematosus	21
Peripheral γδ T Cells Regulate Neutrophil Expansion and Recruitment in Experimental Psoriatic Arthritis	21
Clinical Images: Erdheim‐Chester disease presenting with palpitations and spondylopathy	20
Should Low Serum Urate Be Exonerated? Untangling the Influence of Sarcopenia in Observational Studies	20
Clinical Trials in Systemic Sclerosis: Crossroads and Opportunities	20
Increased Diagnostic Accuracy of the Labial Gland Biopsy in Primary Sjögren Syndrome When Multiple Histopathological Features Are Included	20
Clinical and Methodologic Considerations With Regard to a Trial of Nintedanib in Patients With Systemic Sclerosis‐Associated Interstitial Lung Disease: Comment on the Reanalysis by Maher et al	20
Reply	20
Risk of arrhythmia among new users of hydroxychloroquine: comment on the article by Hoque et al	20
Reply	20
A Novel Human Interleukin‐23A Overexpressing Mouse Model of Systemic Lupus Erythematosus	20
Reply	20
Rheumatology Is Amazing	20
Association of alcohol consumption with disease activity and health‐related quality of life in rheumatoid arthritis: comment on the article by Alfredsson et al	20
Risk of serious infection between belimumab and oral immunosuppressants for non‐renal systemic lupus erythematosus: comment on the article by Materne et al	20
Weighing the Cardiovascular Risks of Low‐Dose Glucocorticoids in Rheumatoid Arthritis From Real‐World Data	20
Reply	20
Multimodal Single‐Cell Sequencing of B Cells in Primary Sjögren's Syndrome	19
Genetics of Childhood‐Onset Systemic Lupus Erythematosus	19
Baricitinib Improves Bone Properties and Biomechanics in Patients With Rheumatoid Arthritis: Results of the Prospective Interventional BARE BONE Trial	19
Some More Equal Than Others: The Divergence of Cardiac Risk in the Use of Nonsteroidal Anti‐Inflammatory Drugs Versus Colchicine for Treating and Preventing Gout	19
The effect of air pollution and genetic susceptibility on systemic lupus erythematosus: comment on the article by Xing et al	19
Urinary Biomarkers Associated With Pathogenic Pathways Reflecting Histologic Findings in Lupus Nephritis	19
A Randomized, Placebo‐Controlled Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled Gout Receiving Pegloticase: Primary Efficacy and Safety Findings	19
The Effect of Discontinuing Denosumab in Patients With Rheumatoid Arthritis Treated With Glucocorticoids	19
Associations Between Changes in Pain Sensitization and Disease Activity Following Disease‐Modifying Antirheumatic Drug Therapy in Established Rheumatoid Arthritis	19
Diversity and Epitope Spreading of Anti–RNA Polymerase III Antibodies in Systemic Sclerosis: A Potential Biomarker for Skin and Lung Involvement	19
ChatGPT, et al…Artificial Intelligence, Authorship, and Medical Publishing	19
Plasmablast‐like Phenotype Among Antigen‐Experienced CXCR5–CD19^low B Cells in Systemic Lupus Erythematosus	19
Clinical Connections	19
Protein Profiling in Presymptomatic Individuals Separates Myeloperoxidase–Antineutrophil Cytoplasmic Antibody and Proteinase 3–Antineutrophil Cytoplasmic Antibody Vasculitides	19
A Genome‐Wide Association Study Meta‐Analysis of Alpha Angle Suggests Cam‐Type Morphology May Be a Specific Feature of Hip Osteoarthritis in Older Adults	19
Distinct Pathophysiologic Pathways Support Stratification of Sjögren's Disease Based on Symptoms, Clinical, and Routine Biological Data	18
Phenotype Risk Score but Not Genetic Risk Score Aids in Identifying Individuals With Systemic Lupus Erythematosus in the Electronic Health Record	18
Amelioration of Posttraumatic Osteoarthritis in Mice Using Intraarticular Silencing of Periostin via Nanoparticle‐Based Small Interfering RNA	18
Transition from psoriasis to psoriatic arthritis is characterized by distinct alterations in peripheral blood Tc17, Th17 and CD4+ TEM cells	18
Long‐Term Efficacy and Safety of Canakinumab in Patients With Tumor Necrosis Factor Receptor–Associated Periodic Syndrome: Results From a Phase III Trial	18
An Immunosenescent CD8+ T Cell Subset in Patients with Axial Spondyloarthritis and Psoriatic Arthritis Links Spontaneous Motility to Telomere Shortening and Dysfunction	18
Gout and Excess Risk of Severe SARS–CoV‐2 Infection Among Vaccinated Individuals: A General Population Study	18
	17
Atherosclerosis Progression in the APPLE Trial Can Be Predicted in Young People With Juvenile‐Onset Systemic Lupus Erythematosus Using a Novel Lipid Metabolomic Signature	17
Clinical Images: Appendix vasculitis in a patient with intestinal Behçet disease	17
Late‐Onset Spondylarthritis Presenting as Glucocorticoid‐Resistant Polymyalgia Rheumatica: A hitherto underappreciated entity where TNF or IL‐17 Blockade may have a Therapeutic R	17
Issue Information	17
Methotrexate Safety and Efficacy in Combination Therapies in Patients With Early Rheumatoid Arthritis: A Post Hoc Analysis of a Randomized Controlled Trial	17
Clinical Connections	17